Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
Crossref DOI link: https://doi.org/10.1007/s40261-016-0437-4
Published Online: 2016-07-15
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosario, Maria
Wyant, Timothy
Leach, Timothy
Sankoh, Serap
Scholz, Catherine
Parikh, Asit
Fox, Irving
Feagan, Brian G.
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
License valid from 2016-07-15